Eaton Vance Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $698K | Hold |
10,000
| – | – | ﹤0.01% | 1292 |
|
|
2022
Q2 | $671K | Sell |
10,000
-20,637
| -67% | -$1.38M | ﹤0.01% | 1323 |
|
|
2022
Q1 | $2.52M | Buy |
30,637
+20,451
| +201% | +$1.68M | ﹤0.01% | 1108 |
|
|
2021
Q4 | $1.49M | Hold |
10,186
| – | – | ﹤0.01% | 1093 |
|
|
2021
Q3 | $1.77M | Buy |
10,186
+184
| +2% | +$32K | ﹤0.01% | 961 |
|
|
2021
Q2 | $1.62M | Sell |
10,002
-450
| -4% | -$72.7K | ﹤0.01% | 1057 |
|
|
2021
Q1 | $1.79M | Buy |
10,452
+451
| +5% | +$77.2K | ﹤0.01% | 1004 |
|
|
2020
Q4 | $2.2M | Buy |
+10,001
| New | +$2.2M | ﹤0.01% | 906 |
|
|
2020
Q3 | – | Sell |
-33,361
| Closed | -$3.81M | – | 1344 |
|
|
2020
Q2 | $3.81M | Hold |
33,361
| – | – | 0.01% | 663 |
|
|
2020
Q1 | $2.56M | Sell |
33,361
-26,925
| -45% | -$2.07M | 0.01% | 702 |
|
|
2019
Q4 | $7.77M | Buy |
+60,286
| New | +$7.77M | 0.02% | 509 |
|